Table 1: Published data on outcomes of similar cementless primary THAs.

ManuscriptImplant
used
Number of hipsMean ageMean Followup
(years)
Revision
(acetabular aseptic loosening)
Revision
(all cause)
DislocationOsteolysis

Anseth et al. (2010) [18]Harris-Galante I/II1135417.22 (1.8%)4 (3.5%) NR2 (1.8%)
Baker et al. (2010) [19]ABG I6953158 (11.6%)8 (11.6%)010 (14.5%)
Belmont et al. (2008) [12]Trispike (DePuy)22371.8209 (4%)26 (11.7%)1 (0.45%)17 (7.6%)
Della Valle et al. (2009) [13]Harris-Galante I2045220.6 5 (4%)10 (8.1%)5/124NR
Chen et al. (2006) [20]Duraloc14556.26.70 (0%)2 (1.4%)9/148 (6.1%)3 (2%)
Streit et al. (2012) [21]Fitmore 894912 0 (0%)5/81, 2 liner exchange1/810 (0%)
Berli et al. (2007) [22]Morscher11214.7 2.5%4.7%
Della Valle et al. (2004) [23]Trilogy308644–71 (0.3%)8 (2.4%)NR12 (5%)
Sugano et al. (2012) [24]Biolox forte935612.41 (1.1%)2 (2.2%) ? (cup only)1 (1.1%)0 (0%)
de Witte et al. (2011) [25]CementLess Spotorno10255.911.89 (8.8%)10 (cup)NRNR
Stefl et al. (2012) [26]Harris-Galante I120NR23.31 (0.8%)22 (18.3%)NR8 (6.7%)
Gottliebsen et al. (2012) [27]Mallory-Head77 HA coated
73 non-HA coated
57 (HA)
63 (non-HA)
11HA coated: 0 (0%)
Non-HA coated: 7 (9.6%)
HA coated: 0%
Non-HA: 9.6%
NRNR